Wikidata entity: Q61387
C₁₉H₂₁N (P274)
Quantities
| P4250 | defined daily dose | 30 |
| P4250 | defined daily dose | 75 |
| P2067 | mass | 263.167 |
| P3780 | active ingredient in | ... | Q47521959 (Pamelor) | Pamelor |
| P233 | canonical SMILES | String | CNCCC=C1C2=CC=CC=C2CCC3=CC=CC=C31 | ??? |
| P373 | Commons category | String | Nortriptyline | ??? |
| P703 | found in taxon | ... | Q104249197 (Senegalia berlandieri) | Senegalia berlandieri |
| P366 | has use | ... | Q12140 (medication) | medication |
| P31 | instance of | ... | Q113145171 (type of chemical entity) | type of chemical entity |
| P2175 | medical condition treated | ... | Q81938 (pain) | pain |
| P2175 | medical condition treated | ... | Q181923 (attention deficit hyperactivity disorder) | attention deficit hyperactivity disorder |
| P2175 | medical condition treated | ... | Q19000444 (neurotic disorder) | neurotic disorder |
| P2175 | medical condition treated | ... | Q544006 (anxiety disorder) | anxiety disorder |
| P129 | physically interacts with | ... | Q410142 (solute carrier family 6 member 4) | solute carrier family 6 member 4 |
| P129 | physically interacts with | ... | Q21497878 (Potassium inwardly-rectifying channel, subfamily J, member 6) | Potassium inwardly-rectifying channel, subfamily J, member 6 |
| P129 | physically interacts with | ... | Q21497881 (Potassium inwardly-rectifying channel, subfamily J, member 5) | Potassium inwardly-rectifying channel, subfamily J, member 5 |
| P129 | physically interacts with | ... | Q7050954 (Solute carrier family 6 member 2) | Solute carrier family 6 member 2 |
| P129 | physically interacts with | ... | Q21113510 (potassium inwardly rectifying channel subfamily J member 10) | potassium inwardly rectifying channel subfamily J member 10 |
| P3489 | pregnancy category | ... | Q3679261 (Australian pregnancy category C) | Australian pregnancy category C |
| P769 | significant drug interaction | ... | Q402633 ((±)-deprenyl) | (±)-deprenyl |
| P769 | significant drug interaction | ... | Q409595 (isocarboxazid) | isocarboxazid |
| P769 | significant drug interaction | ... | Q418656 (procarbazine) | procarbazine |
| P769 | significant drug interaction | ... | Q420885 (tranylcypromine) | tranylcypromine |
| P769 | significant drug interaction | ... | Q1747559 (phenelzine) | phenelzine |
| P279 | subclass of | ... | Q76722904 (dibenzocycloheptene) | dibenzocycloheptene |
| P2868 | subject has role | ... | Q334477 (selective serotonin reuptake inhibitor) | selective serotonin reuptake inhibitor |
| P2868 | subject has role | ... | Q899668 (adrenergic uptake inhibitors) | adrenergic uptake inhibitors |
| P2868 | subject has role | ... | Q908843 (tricyclic antidepressant) | tricyclic antidepressant |
| P2275 | World Health Organisation international non-proprietary name | Monolingualtext | nortriptyline | ??? |
Why not click here or view trends?
log id: 2978496